Strategies in regulating glioblastoma signaling pathways and anti-invasion therapy

PLoS One. 2019 Apr 22;14(4):e0215547. doi: 10.1371/journal.pone.0215547. eCollection 2019.

Abstract

Glioblastoma multiforme is one of the most invasive type of glial tumors, which rapidly grows and commonly spreads into nearby brain tissue. It is a devastating brain cancer that often results in death within approximately 12 to 15 months after diagnosis. In this work, optimal control theory was applied to regulate intracellular signaling pathways of miR-451-AMPK-mTOR-cell cycle dynamics via glucose and drug intravenous administration infusions. Glucose level is controlled to activate miR-451 in the up-stream pathway of the model. A potential drug blocking the inhibitory pathway of mTOR by AMPK complex is incorporated to explore regulation of the down-stream pathway to the cell cycle. Both miR-451 and mTOR levels are up-regulated inducing cell proliferation and reducing invasion in the neighboring tissues. Concomitant and alternating glucose and drug infusions are explored under various circumstances to predict best clinical outcomes with least administration costs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / genetics*
  • AMP-Activated Protein Kinases / metabolism
  • Algorithms
  • Antineoplastic Agents / pharmacology
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / metabolism
  • Cell Movement / drug effects
  • Cell Movement / genetics
  • Cell Proliferation / drug effects
  • Cell Proliferation / genetics
  • Gene Expression Regulation, Neoplastic / drug effects
  • Glioblastoma / drug therapy
  • Glioblastoma / genetics*
  • Glioblastoma / metabolism
  • Glucose / metabolism
  • Glucose / pharmacology
  • Humans
  • MicroRNAs / genetics*
  • Neoplasm Invasiveness
  • Signal Transduction / drug effects
  • Signal Transduction / genetics*
  • TOR Serine-Threonine Kinases / genetics*
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Antineoplastic Agents
  • MIRN451 microRNA, human
  • MicroRNAs
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • AMP-Activated Protein Kinases
  • PRKAA1 protein, human
  • Glucose

Grants and funding

This work is resulted from the Konkuk University research support program (E.J.). This paper is also supported by the Korea National Research Foundation (NRF) grant funded by the Korean government (MEST): NRF- 2017R1A2B2004651 (E.J.) and the Basic Science Research Program through National Research Foundation of Korea (NRF) funded by Ministry of Science, ICT and Future Planning: (2018R1A2B6007288) (Y.K.). This work was funded by the University of the Philippines System Enhanced Creative Work and Research Grant (ECWRG 2016-1-030). K.J.A.P. is supported by the University of the Philippines-Office of International Linkages-Continuous Operational and Outcomes-based Partnership for Excellence in Research and Academic Training Enhancement (UP-OIL-COOPERATE) grant and the Department of Science and Technology-Accelerated Science and Technology Human Resource Development Program-National Science Consortium (DOST-ASTHRDP-NSC) Scholarship.